Kast WM - Search Results

1

The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infection.

Woodham AW, Da Silva DM, Skeate JG, Raff AB, Ambroso MR, Brand HE, Isas JM, Langen R, Kast WM. Woodham AW, et al. Among authors: kast wm. PLoS One. 2012;7(8):e43519. doi: 10.1371/journal.pone.0043519. Epub 2012 Aug 22. PLoS One. 2012. PMID: 22927980 Free PMC article.

2

Induction of HPV16 capsid protein-specific human T cell responses by virus-like particles.

Rudolf MP, Nieland JD, DaSilva DM, Velders MP, Müller M, Greenstone HL, Schiller JT, Kast WM. Rudolf MP, et al. Among authors: kast wm. Biol Chem. 1999 Mar;380(3):335-40. doi: 10.1515/BC.1999.045. Biol Chem. 1999. PMID: 10223336

3

Papillomavirus virus-like particles as anticancer vaccines.

Da Silva DM, Velders MP, Rudolf MP, Schiller JT, Kast WM. Da Silva DM, et al. Among authors: kast wm. Curr Opin Mol Ther. 1999 Feb;1(1):82-8. Curr Opin Mol Ther. 1999. PMID: 11249689 Review.

4

Physical interaction of human papillomavirus virus-like particles with immune cells.

Da Silva DM, Velders MP, Nieland JD, Schiller JT, Nickoloff BJ, Kast WM. Da Silva DM, et al. Among authors: kast wm. Int Immunol. 2001 May;13(5):633-41. doi: 10.1093/intimm/13.5.633. Int Immunol. 2001. PMID: 11312251

5

Human dendritic cells are activated by chimeric human papillomavirus type-16 virus-like particles and induce epitope-specific human T cell responses in vitro.

Rudolf MP, Fausch SC, Da Silva DM, Kast WM. Rudolf MP, et al. Among authors: kast wm. J Immunol. 2001 May 15;166(10):5917-24. doi: 10.4049/jimmunol.166.10.5917. J Immunol. 2001. PMID: 11342606

6

Effect of preexisting neutralizing antibodies on the anti-tumor immune response induced by chimeric human papillomavirus virus-like particle vaccines.

Da Silva DM, Pastrana DV, Schiller JT, Kast WM. Da Silva DM, et al. Among authors: kast wm. Virology. 2001 Nov 25;290(2):350-60. doi: 10.1006/viro.2001.1179. Virology. 2001. PMID: 11883199 Free article.

7

Human papillomavirus virus-like particles do not activate Langerhans cells: a possible immune escape mechanism used by human papillomaviruses.

Fausch SC, Da Silva DM, Rudolf MP, Kast WM. Fausch SC, et al. Among authors: kast wm. J Immunol. 2002 Sep 15;169(6):3242-9. doi: 10.4049/jimmunol.169.6.3242. J Immunol. 2002. PMID: 12218143

8

HPV protein/peptide vaccines: from animal models to clinical trials.

Fausch SC, Da Silva DM, Eiben GL, Le Poole IC, Kast WM. Fausch SC, et al. Among authors: kast wm. Front Biosci. 2003 Jan 1;8:s81-91. doi: 10.2741/1009. Front Biosci. 2003. PMID: 12456298 Review.

9

Comparison of human papillomavirus type 16 L1 chimeric virus-like particles versus L1/L2 chimeric virus-like particles in tumor prevention.

Wakabayashi MT, Da Silva DM, Potkul RK, Kast WM. Wakabayashi MT, et al. Among authors: kast wm. Intervirology. 2002;45(4-6):300-7. doi: 10.1159/000067921. Intervirology. 2002. PMID: 12566713

10

Heterologous boosting increases immunogenicity of chimeric papillomavirus virus-like particle vaccines.

Da Silva DM, Schiller JT, Kast WM. Da Silva DM, et al. Among authors: kast wm. Vaccine. 2003 Jul 4;21(23):3219-27. doi: 10.1016/s0264-410x(03)00237-8. Vaccine. 2003. PMID: 12804851

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

276 results

Search Page

Filters